Metabolic Benefits Beyond Weight Loss Weight loss represents the most visible outcome, but both peptides produce metabolic improvements that extend far beyond the number on the scale
On March 3, 2026, the drug administration fda issued over 30 warning letters to companies illegally marketing compounded versions of glp-1 medications , including investigational peptides like retatrutide
Many users report significant improvements in healing times, reduced pain, and enhanced mobility following treatment
While compounding can address unique patient needs, it may not always provide the same level of evidence-based effectiveness that comes with FDA-approved medications
and Supplementary Data 1 and 2) in skeletal muscle, but not in liver, consistent with our previous study 15